BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 26424523)

  • 1. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review.
    Raghu G; Amatto VC; Behr J; Stowasser S
    Eur Respir J; 2015 Oct; 46(4):1113-30. PubMed ID: 26424523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.
    Suzuki A; Kondoh Y
    Respir Investig; 2017 Mar; 55(2):94-103. PubMed ID: 28274539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A review.
    de Boer K; Lee JS
    Respirology; 2016 Aug; 21(6):995-1004. PubMed ID: 26365251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic pulmonary fibrosis: Clinical behavior and aging associated comorbidities.
    Buendía-Roldán I; Mejía M; Navarro C; Selman M
    Respir Med; 2017 Aug; 129():46-52. PubMed ID: 28732835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusters of comorbidities in idiopathic pulmonary fibrosis.
    Prior TS; Hoyer N; Hilberg O; Shaker SB; Davidsen JR; Rasmussen F; Bendstrup E
    Respir Med; 2021; 185():106490. PubMed ID: 34130097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
    Oda K; Yatera K; Fujino Y; Kido T; Hanaka T; Sennari K; Fushimi K; Matsuda S; Mukae H
    Respir Investig; 2018 Jan; 56(1):64-71. PubMed ID: 29325684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidities of IPF: How do they impact on prognosis.
    Torrisi SE; Vancheri A; Pavone M; Sambataro G; Palmucci S; Vancheri C
    Pulm Pharmacol Ther; 2018 Dec; 53():6-11. PubMed ID: 30193867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Helicobacter pylori in Idiopathic Pulmonary Fibrosis Lung Biopsies.
    Kreuter M; Kirsten D; Bahmer T; Penzel R; Claussen M; Ehlers-Tenenbaum S; Muley T; Palmowski K; Eichinger M; Leider M; Herth FJ; Rabe KF; Bittmann I; Warth A
    Respiration; 2016; 91(1):3-8. PubMed ID: 26645213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic pulmonary fibrosis is associated with increased impedance measures of reflux compared to non-fibrotic disease among pre-lung transplant patients.
    Gavini S; Finn RT; Lo WK; Goldberg HJ; Burakoff R; Feldman N; Chan WW
    Neurogastroenterol Motil; 2015 Sep; 27(9):1326-32. PubMed ID: 26176338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IPF, comorbidities and management implications.
    Vancheri C; Cottin V; Kreuter M; Hilberg O
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():17-23. PubMed ID: 26237439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic pulmonary fibrosis: phenotypes and comorbidities.
    Fell CD
    Clin Chest Med; 2012 Mar; 33(1):51-7. PubMed ID: 22365245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?
    Alfaro TM; Robalo Cordeiro C
    Ther Adv Respir Dis; 2020; 14():1753466620910092. PubMed ID: 32167024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.
    Frank AL; Kreuter M; Schwarzkopf L
    Respir Med; 2019 Jun; 152():25-31. PubMed ID: 31128606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night.
    Schiza S; Mermigkis C; Margaritopoulos GA; Daniil Z; Harari S; Poletti V; Renzoni EA; Torre O; Visca D; Bouloukaki I; Sourvinos G; Antoniou KM
    Eur Respir Rev; 2015 Jun; 24(136):327-39. PubMed ID: 26028644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis.
    Gille T; Didier M; Boubaya M; Moya L; Sutton A; Carton Z; Baran-Marszak F; Sadoun-Danino D; Israël-Biet D; Cottin V; Gagnadoux F; Crestani B; d'Ortho MP; Brillet PY; Valeyre D; Nunes H; Planès C;
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28596432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing complications and co-morbidities of fibrotic interstitial lung disease.
    Margaritopoulos GA; Kokosi MA; Wells AU
    Expert Rev Respir Med; 2019 Jul; 13(7):645-658. PubMed ID: 31215263
    [No Abstract]   [Full Text] [Related]  

  • 17. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis.
    Raghu G; Freudenberger TD; Yang S; Curtis JR; Spada C; Hayes J; Sillery JK; Pope CE; Pellegrini CA
    Eur Respir J; 2006 Jan; 27(1):136-42. PubMed ID: 16387946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic pulmonary fibrosis: evolving concepts.
    Ryu JH; Moua T; Daniels CE; Hartman TE; Yi ES; Utz JP; Limper AH
    Mayo Clin Proc; 2014 Aug; 89(8):1130-42. PubMed ID: 24867394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.
    Mortimer K; Hartmann N; Chan C; Norman H; Wallace L; Enger C
    BMC Pulm Med; 2019 Jan; 19(1):11. PubMed ID: 30630460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases.
    King C; Nathan SD
    Curr Opin Pulm Med; 2013 Sep; 19(5):466-73. PubMed ID: 23912191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.